Multi-dimensional evidence from the UK Biobank shows the impact of diet and macronutrient intake on aging

Introduction

Aging is a complex biological process involving molecular changes, cellular senescence, and physiological dysregulation1. While chronological aging is inevitable, biological aging varies among individuals due to genetic and environmental factors2. Geroscience theory posits that slowing biological aging could prevent diseases, extend healthy lifespan, and reduce healthcare costs1,3. Lifestyle factors such as diet, alcohol consumption, smoking, and physical activity significantly influence aging4,5. Diet, in particular, directly impacts health outcomes, including chronic diseases, serum biomarkers, and DNA methylation, suggesting its potential role in modulating aging6,7,8.

However, research on specific dietary patterns and their effects on aging has yielded inconsistent and inconclusive results9. These discrepancies can be attributed to varying methods of measuring biological aging, limited sample sizes, and a lack of controlled trials or robust causal inference approaches. For instance, while some studies suggest that low-carbohydrate diets improve serum factors related to aging, others link these diets to higher mortality rates10,11. Similarly, reviews on diet’s impact on cognitive aging and telomere length report mixed outcomes12,13,14.

Given the imperative to promote healthy aging—a state where individuals maintain functional abilities that enable well-being—the lack of clear guidance from existing studies is a significant gap in knowledge. This study aims to systematically investigate the relationships between dietary factors and multidimensional measures of aging (i.e., telomere length, clinical biomarkers-based phenotypical age, and brain volumetric measurements of grey/white matter volumes), focusing particularly on the causal impacts of macronutrient intakes using cohort study data. Our goal is to clarify the role of diet in biological aging processes and provide robust evidence to support dietary recommendations for healthy aging. In this study, we find that healthier diets, particularly those rich in carbohydrates, are linked to slower aging and improved brain health. In addition, plant-based foods show benefits, while animal-based diets are linked to negative effects on healthy aging.

Methods

Study sample and data

Our analysis draws dietary, biomarker, and socio-demographic data from the UK Biobank baseline survey. UK Biobank is the database for a population-based study involving 502,409 UK residents approved by the NHS National Research Ethics Service (ref. 11./NW/0382). Between March 2006 and July 2010, individuals residing within 25 miles of one of the 22 study assessment centers in England, Scotland, and Wales were recruited to provide data on a wide range of socio-demographic, clinical, and lifestyle outcomes. Blood, urine, and saliva samples, as well as physical measurements, were collected from all participants with their written informed consent during the interviews. For this study, permission to access and analyse the UK Biobank data was approved under the application numbered 89068.

At the baseline (2006), a food frequency touchscreen questionnaire was used to collect data on all participants’ dietary habits14, including single food intakes (e.g., cooked vegetables consumed), food types (e.g., types of cereal primarily consumed), and intake frequencies (e.g., frequency of oily fish consumption). Observations (7848 participants) with unrealistic answers were dropped. In early 2009, the main UK Biobank study protocol further included the Oxford WebQ, a web-based dietary assessment tool that asks about the consumption of up to 206 types of foods and 32 types of drinks during the previous 24 h15,16. In total, 210,977 participants had completed at least one assessment.

Serum biomarker data used to construct phenotypic age were obtained from the UK Biobank blood samples collected from all participants at the baseline and analyzed within 24 h of the blood draw with Beckman Coulter LH750 instruments at the UK Biobank central laboratory17.

Participants’ genotypes were analyzed with the Affymetrix (Santa Clara, CA, USA) UK Biobank Axiom Array and the UK BiLEVE Axiom Array. Information regarding principal components analysis and genetic principal components is provided elsewhere18. Telomere length data measuring biological age were also derived from the DNA samples19.

High-quality MRI (magnetic resonance imaging) brain imaging data were available for a subset of participants (N = 42,942) upon additional agreement. These data were acquired using a Siemens Skyra 3 T scanner (Siemens Healthcare, Erlangen, Germany) with a standard 32-channel head coil. Structural imaging and diffusion data were processed by UK Biobank technicians and made available to approved researchers as imaging-derived phenotypes (IDPs)20,21.

Measurements of dietary factors

Individual food intake

The consumption of seven common food groups (vegetables, fruits, grains, fish, meat, dairy products, and beverages) and intakes of 18 specific food categories were investigated: cooked vegetables (tablespoons/day), salad/raw vegetables (tablespoons/day), fresh fruits (pieces/day), dried fruits (pieces/day), bread (pieces/day), cereal (bowls/week), oily fish (times/week), non-oily fish (times/week), processed meat (times/week), poultry (times/week), beef (times/week), lamb/mutton (times/week), pork (times/week); cheese (times/week), milk (full cream/semi-skimmed/skimmed=1; never/rarely consumed/soya=0), hot drinks (very hot/hot=1; warm/never hot drinks=0), coffee (cups/day), and tea (cups/day). Detailed UK Biobank data field codes were provided in Supplementary Table 1.

Dietary patterns

This study considers six dietary patterns: low-carb, high-carb, high-protein, low-fat, high fat, and ketogenic diets, which are defined based on the absolute intake of a macronutrient as a function of body weight or a proportion to total energy intake—Supplementary Table 2 provides more details.

Macronutrient intake

Daily macronutrient intakes of carbohydrates, protein, and fat (all in grams) were calculated by UK Biobank experts based on responses from the computerized 24-hour dietary recall follow-up questionnaire (described above)15,16. Data were available for 210,977 participants in this study.

Diet quality scores

Following detailed protocols provided by FAO (Food and Agriculture Organization) and USDA (US Department of Agriculture) guidelines, we calculated three diet-quality scores using the 24-hour dietary recall data: Individual Diet Diversity Score (IDDS)22,23, Healthy Eating index (HEI-2015)24, and Dietary Approaches to Stop Hypertension (DASH) index25.

Measurements of aging

Telomere length

Leucocyte telomere length (LTL) was measured using an established multiplex qPCR assay on DNA samples from UK Biobank participants. After extensive quality checks and adjustments for technical factors, 473,994 participants in our sample had valid LTL measurements. The LTL was then log-transformed to yield an approximately normal distribution and z-standardized using the distribution of all individuals with valid LTL measurements19.

Clinical biomarkers-based phenotypic age

Clinical biomarkers-based phenotypic age was determined using chronological age and nine clinical biomarkers as proposed by Yang et al.4: albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean corpuscular volume, red cell distribution width, alkaline phosphatase, and white blood cell count4. Employing a parametric proportional hazards model based on the Gompertz distribution, this approach calculates a “phenotypic age” by modeling 10-year mortality risk, offering a robust quantifiable measure of biological aging. Biomarker data were obtained from UK Biobank samples collected at enrollment, typically analyzed within 24 h at the central laboratory using Beckman Coulter LH750 instruments.

Grey/white matter volume

Participants’ whole-brain grey and white matter volume data (normalized for head size) were obtained from the UK Biobank brain imaging datasets.

Covariates

To control for potential confounding factors, we included a series of socio-demographic, physiological, and genetic characteristics in the statistical analysis: gender, chronological age, education (whether with a college/university degree), body mass index (BMI), top ten genetic principal components (PCs), and the Townsend Deprivation Index (TDI)—a measure of local material deprivation: positive (negative) numbers indicate lower (higher) socioeconomic status.

Statistics and Reproducibility

Statistical models

We used four measures of aging (telomere length, clinical biomarkers-based phenotypic age, whole-brain grey matter volume, and whole-brain white matter volume) as the primary outcomes and four sets of dietary factors (dietary habits/food intake, dietary patterns, macronutrient intakes, and diet quality scores) as main explanatory variables.

First, high-dimensional fixed effects (HDFE) models26 were fitted to examine the associations of dietary factors with aging while controlling for a large number of occupational, ethnicity, regional, and ethnicity-by-region fixed effects (FEs) to mitigate unobserved confounding. HDFE is essential for accurately identifying the influence of confounding variables across varied ethnic, regional, and occupational groups. It has particular advantages over traditional multivariate linear regression when handling large numbers of fixed effects or multi-dimensionally clustered standard errors. In those cases, HDFE can adjust degrees of freedom more efficiently, providing more precise estimates (i.e., with smaller standard errors) under complex fixed-effect structures when standard errors are clustered in multiple dimensions. Additionally, HDFE offers superior computational efficiency, which is especially important when dealing with very large datasets and numerous covariates. The HDFE models take the following form:

$${Aging} ={{{boldsymbol{lambda }}}}{{{boldsymbol{Psi }}}}+{{{boldsymbol{beta }}}}{{{boldsymbol{X}}}}+{theta }_{1}O{ccupation}+{theta }_{2}{Ethinicity}+{theta }_{3}{Region} \ quad+,{theta }_{4}{Ethnicity}{{{rm{_}}}}{Region}+varepsilon$$
(1)

where ({Aging}) is one of the four aging measures of interest; ({{{boldsymbol{Psi }}}}) represents a particular set of dietary factors (e.g., dietary patterns or macronutrient intakes); ({{{boldsymbol{lambda }}}}) is the parameter vector of primary interest; X is the set of covariates discussed above; also included are a total of 477 FEs: 336 occupational FEs, 18 race/ethnicity FEs, 10 regional FEs, and 113 race/ethnicity-by-region FEs; ε is a disturbance term. A detailed list of the 477 fixed effects used in HDFE were provided in Supplementary Data 1.

Second, we address the potential endogeneity and interrelatedness of macronutrient intakes using a Multivariate Mendelian Randomization (MVMR) framework. This approach leverages multiple genetic variants as instrumental variables (IVs) to simultaneously assess the effects of multiple related endogenous dietary exposures on outcomes27. The strength of Mendelian randomization stems from the random allocation of genes at meiosis, resembling random treatment assignments in randomized controlled trials that may be infeasible or unethical in our setting28. MVMR improves upon traditional univariate MR by incorporating multiple genetic instruments and accounting for the interrelations among different macronutrient intakes, thereby deriving more robust causal inferences. The combination of the HDFE approach and MVMR analysis forms a triangulation design, which can strengthen findings when different statistical methods, based on distinct assumptions, reach the same conclusion28,29. The STROBE-MR checklist is available elsewhere30.

Based on recent genome-wide association studies (GWAS) that identified genetic variants that are closely related to diet compositions and macronutrient intakes31, we used nine independent single nucleotide polymorphisms (SNPs)—rs10510554, rs8097672, rs10206338, rs10962121, rs2472297, rs33988101, rs57193069, rs1461729, and rs445551—as genetic IVs in our MVMR design32. To rule out potential mediating effects of genetic variants on aging outcomes via other traits that could violate the statistical assumptions of MR designs33, these SNPs were selected based on functional annotation results from SNPnexus and GWAS Catalog online tools34,35. Detailed information on these SNPs, including chromosome, position, effect allele, alternative allele, effect allele frequency, beta values, p-values, and nearest gene were provided in Supplementary Table 3. It is worth noting that we selected only a subset of dietary markers (namely, dietary intakes of carbohydrates, proteins, and fats) for MVMR, given data on these macronutrients robustly available from previous genome-wide association studies, to ensure the reliability of MR results31. Formally, we estimate the following two-stage least-squares (2SLS) specifications:

First stage:

$${carbohydrate}={delta }^{{carb}}{{{boldsymbol{G}}}}+{mu }^{{carb}}{{{boldsymbol{X}}}}+{pi }_{1}^{{carb}}{Ethinicity}+{pi }_{2}^{{carb}}{Region}+{xi }^{{carb}}$$
(2a)
$${protein} ={delta }^{{protein}}{{{boldsymbol{G}}}}+{mu }^{{protein}}{{{boldsymbol{X}}}}+{pi }_{1}^{{protein}}{Ethinicity}\ quad +{pi }_{2}^{{protein}}{Region}+{xi }^{{protein}}$$
(2b)
$${fat}={delta }^{{fat}}{{{boldsymbol{G}}}}+{mu }^{{fat}}{{{boldsymbol{X}}}}+{pi }_{1}^{{fat}}{Ethinicity}+{pi }_{2}^{{fat}}{Region}+{xi }^{{fat}}$$
(2c)

Second stage:

$${Aging} = ,{gamma }^{{carb}}overline{{carbohydrate}}+{gamma }^{{protein}}overline{{protein}}+{gamma }^{{fat}}overline{{fat}}+mu {{{boldsymbol{X}}}}\ +{rho }_{1}{Ethinicity}+{rho }_{2}{Region}+epsilon$$
(3)

Mechanically, in the first stage (Equations 2a–2c), each of the macronutrient intakes is regressed on a set of nine genetic IVs (({{{boldsymbol{G}}}})), the set of covariates (X), ethnicity fixed effects, and regional fixed effects. In the second stage (Equation 3), each aging outcome is regressed on the fitted values of all three macronutrient intakes simultaneously, along with all control variables used in the first stage. In practice, all regressions involved in the 2SLS framework were performed at once using STATA 15. A detailed list of the 28 fixed effects used in MVMR were provided in Supplementary Table 4.

In each model, we excluded those with missing data on particular dietary factors, aging outcomes, or genotyping information, resulting in 24,875 to 493,478 participants in different regression models. All regressions were followed by Sidak-Holm post hoc analyses to correct for multiple comparisons36,37.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Results

Summary statistics

Among all 493,478 participants, 45.7% are male; 54.3% are female (Table 1). Over 90% of the participants are White; 32.2% had a college/university degree. The average participant was 56.5 years old, with a BMI of 27.2 kg/m2 and a Townsend Deprivation Index of −1.3, consuming 255 grams of carbohydrates, 78 grams of fat, 82 grams of protein, and a total of 2121 calories daily. Detailed pairwise Pearson’s correlation coefficients between aging outcomes and dietary exposures are displayed in Fig. 1, panel a and panel b, respectively.

Table 1 Summary statistics of the analytical sample (N = 493,478)
Full size table
Fig. 1: Pairwise Pearson’s correlation coefficients of aging outcomes and dietary exposures.
figure 1

a Correlation coefficients of aging outcomes. b Correlation coefficients of dietary exposures. # and * represent statistical significance at p < 0.01 and p < 0.05, respectively.

Full size image

Associations of dietary factors with aging

In our HDFE analyses, we found 45 significant associations out of 120 between individual food intakes, dietary patterns, daily intakes of macronutrients, diet quality scores, and four measures of aging, after applying the Sidak-Holm post hoc correction for multiple comparisons. Figure 2 presents a heatmap summarizing estimated effects of all dietary exposures (in rows) on different aging outcomes (in columns), where red dots indicate potential risky effects, green dots indicate protective effects, and white dots indicate null (i.e., insignificant after the Sidak-Holm correction for multiple testing) effects on specific measures of aging. Detailed information on effect sizes (i.e., beta), original p values, and p values after the Sidak-Holm correction of all estimated parameters are included in Supplementary Data 2.

Fig. 2: Associations between dietary factors and various aging outcomes from high-dimensional fixed effects (HDFE) estimation.
figure 2

a Individual food intakes. b Dietary patterns. c Macronutrients. d Diet quality scores. Colored dots represent statistically significant HDFE estimates of each dietary factor (in rows) on four aging outcomes (in columns) after the Sidak-Holm correction for multiple testing. In specific, red dots indicate risky effects, green dots indicate protective effects, and white dots indicate null effects. Detailed estimation results on effect sizes (i.e., beta), original p values, and p values after the Sidak-Holm correction are included in Supplementary Data 2.

Full size image

Individual food intakes and aging

For individual food intakes, as illustrated in panel a of Fig. 2, we observed that animal-based foods generally have adverse effects on aging. For instance, processed meat intake is significantly correlated with both shorter telomere length and increased biomarkers-based phenotypical age. Similarly, intakes of beef, lamb/mutton, pork, and milk are associated with elevated biomarkers-based phenotypical ages. Conversely, plant-based foods show potential anti-aging benefits; for example, consumption of cooked/raw vegetables and fresh/dried fruits is linked to longer telomeres and/or reduced phenotypic age. Cereal intake is positively associated with longer telomere length, a younger phenotypical age, and greater grey matter volume, though bread intake shows an adverse association with phenotypical age. Among beverages, while tea intake shows negative associations with aging markers, hot drinks are linked with a younger phenotypical age.

It is notable that some foods and beverages show mixed effects on aging outcomes. For example, oily fish intake is beneficial for phenotypic age but negatively impacts grey matter volume. Cheese consumption is associated with both increased telomere length and a younger phenotypical age, yet it also correlates with reduced brain grey/white matter volumes. Surprisingly, coffee, despite its adverse association with telomere length and grey matter volume, is beneficially linked with reduced phenotypic age.

Dietary patterns and aging

Figure 2, panel b, reports estimated associations of six dietary patterns with aging. Two common dietary patterns display consistently adverse effects: (1) a low-carbohydrate diet is negatively associated with three of the four aging outcomes (column 1, 3, and 4); and (2) a high-fat diet is linked to reduced brain grey and white matter volumes. Conversely, a high-protein diet appears to benefit white matter volume of brain. A low-fat diet shows mixed effects; while it is linked to reduced grey matter volume, it is also associated with a decrease in biomarkers-based phenotypic age.

Macronutrients and aging

Figure 2, panel c, highlights the associations between macronutrient intake and aging outcomes. Specifically, carbohydrate intake is beneficially linked to both a younger biomarkers-based phenotypic age and a larger grey matter volume. Conversely, fat intake is associated with an increase in phenotypic age. No significant associations between protein intake and aging outcomes were found after the correction for multiple testing.

Diet quality and aging

Figure 2, panel d, illustrates positive associations between three common diet quality scores and aging outcomes. The three diet quality scores—HEI-2015, DASH, and Food Diversity Index—are all beneficially linked to reduced blood-based phenotypic ages. Additionally, higher HEI-2015 and Food Diversity Index scores are associated with longer telomere lengths.

However, these diet quality scores do not show significant associations with grey/white matter volumes, suggesting that while these metrics effectively capture benefits on telomere length and blood-based phenotypic age, they may not adequately reflect aging-related changes in brain health. This highlights the need for an improved dietary assessment toolbox to comprehensively evaluate the impact of diet across various aspects of aging closely related to individual well-being.

Calorie restriction and aging

Calorie restriction (CR) has been recently associated with increased longevity and improved health in both model organisms and humans38,39. To further explore the role of caloric intake, we conducted additional HDFE regressions on various aging measures based on daily total caloric intake (in 1000 calories). Initially, the models only included a set of previously described fixed effects; subsequently, we added controls for gender, age, education, BMI, and TDI. Our findings, as detailed in Supplementary Table 5, indicate that the associations of caloric intake with aging outcomes were not robust once adjusted for individual factors. This suggests that the nutritional composition of diets plays a more critical role in aging than mere calorie restriction. In essence, not all dietary calories are equivalent in their impact on the aging process, underscoring the unique effects of different food groups and diet compositions examined in this study.

Overall, the HDFE estimates presented here provide initial evidence that numerous dietary factors are associated with different dimensions of aging. The findings reveal a generally protective role of plant-based foods and carbohydrates, while certain animal-based foods and fats exhibit adverse effects, suggesting that reasonable dietary modifications can promote healthy aging. The varied effects of specific foods and dietary patterns indicate a complex relationship between diet and aging, emphasizing the need for further research to elucidate the causality and underlying mechanisms to refine dietary guidelines. To further enhance the robustness of our findings, we also performed conventional ordinary least squares regressions (OLS). As reported in Supplementary Data 3, the estimated coefficients from HDFE and OLS are nearly identical to the fourth decimal place. However, the raw p-values from OLS are generally larger than those from HDFE, reflecting reduced estimation efficiency in OLS. This comparison underscores the advantage of HDFE in terms of computational efficiency and statistical precision.

Causal relationships between macronutrient intakes and aging

To address unobserved confounding that may contaminate the estimated food-intake and dietary-habit effects on aging, we employ the MVMR method to identify the causal effects of three macronutrient intakes simultaneously27,32,40. As noted above, MVMR uses genetic variants associated with diet compositions of carbohydrates, protein, and fat as IVs for their intakes. Nine independent SNPs were selected as genetic IVs based on recent GWAS findings31. The validity of jointly using these SNPs as genetic IVs has been established32. The Sidak-Holm post hoc correction for multiple comparisons were applied to all MVMR models.

As reported in Table 2, the First-stage F-statistics from all MVMR models exceeded the conventional cut-off of 10 for weak-IV tests, suggesting that the nine SNPs are jointly strong IVs in our MVMR design. Supplementary Table 6 reports detailed first-stage regression results. Meanwhile, overidentification (Sargan) tests revealed no evidence of directional pleiotropy, suggesting that our genetic IVs are not likely to be correlated with unobserved confounders.

Table 2 Causal associations of macronutrients with aging from Multivariable Mendelian Randomization (MVMR) estimation
Full size table

The raw MVMR estimates reveal a potential protective effect of carbohydrate intake against aging, evidenced by a reduction in phenotypic age (beta = -0.0025, p = 0.0253) and an increase in grey matter volume (beta = 0.0262, p = 0.0087). The beneficial effect of carbohydrate intake on grey matter volume remains significant even after correcting for multiple comparisons (beta = 0.0262, Sidak-Holm corrected p = 0.0399). In contrast, no significant causal associations were observed between protein or fat intakes and aging outcomes after correction for multiple testing.

Lemaitre et al.41 estimated that the annual grey matter volume (GMV) reduction is 1.89 cm3 due to aging41. Notably, our MVMR results show that an increase of 100 grams in daily carbohydrate intake is significantly associated with an increase in grey matter volume (GMV) by 2.62 cm3, which potentially offsets brain aging by approximately 1.4 years. Furthermore, our findings suggest that the benefits from this dietary adjustment could be comparable to those achieved through physical activity, as reported in Koblinsky et al.42, where physical activity increased total GMV by 2.17 cm342.

To further enhance the robustness of our findings, we also employed a Simultaneous Equation Model (SEM) framework. As reported in Supplementary Data 4, the SEM estimates also indicate a potential protective effect of carbohydrate intake against aging, as evidenced by a reduction in phenotypic age and an increase in grey matter volume, aligning with the MVMR findings.

Discussion

This study identified several dietary factors significantly linked to the acceleration or deceleration of aging. Notably, a low-carb diet was associated with accelerated aging, indicated by shorter telomere length and reduced grey/white matter volumes, and triangulated evidence from HDFE and MVMR designs highlights a significant protective effect of carbohydrate intake against aging. These findings underscore the critical role diet plays in influencing biological aging. Our study also shows that existing diet quality scores, such as DASH and HEI-2015, may not fully capture diet’s impact on brain health, indicating a need for more comprehensive dietary assessment tools.

While previous studies have reported that carbohydrate-rich diets were associated with accelerated aging in model organisms, such as yeast and roundworms (Caenorhabditis elegans), direct evidence regarding whether different levels of carbohydrate intake influence aging in humans remains lacking43,44. The current study adds to the literature by underscoring that in humans, carbohydrates may actually play a beneficial role, particularly in reducing phenotypic age and enhancing brain health.

Several potential explanations may account for the beneficial effects of carbohydrate intake on various aspects of aging. For instance, Seidelmann et al.45 found that a low-carbohydrate diet posed the greatest mortality risk, closely related to epigenetic biomarkers of aging45,46. Furthermore, Jensen et al.47 reported that diets rich in fruits and vegetables and low in meat are linked to increased brain volume and connectivity. The CPLX3 gene, a key marker of subplate neurons in the brain involved in cortical development and plasticity, is also associated with cereal intake47,48. In our sample, higher daily carbohydrate intake correlated with higher intakes of cereal, bread, and fresh/dried fruits. Additionally, Yao et al.32 reported a causal relationship between higher carbohydrate intake and lower depression risk, with depression and cognitive dysfunction sharing a common neuropathological platform in cortical and sub-cortical brain areas32,49.

Our study has several potential limitations that should be considered when interpreting the results. First, the participants were predominantly white, relatively healthy, and well-educated, which may limit the generalizability of our findings to other populations. Second, MVMR estimates from unrelated individuals can be biased due to population structure, assortative mating, and genetic nurture. Future research could address these biases by employing a within-family design. Finally, our study does not verify the biological mechanisms underlying the beneficial effects of carbohydrate intake on aging, which may require randomized diet interventions for verification.

Notwithstanding these limitations, our study highlights the fundamental benefits of certain dietary factors, particularly carbohydrate intake, in combating multifaceted aspects of aging. Given that brain volumetric measurements are strong predictors of longitudinal cognitive change42, our findings imply that a carbohydrate-rich diet may help maintain cognitive health. With 35.4% of the global population unable to afford a healthy diet50, these insights can inform the design of more cost-effective dietary interventions aimed at promoting healthy aging and enhancing individual well-being.

Related Articles

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Type 2 immunity in allergic diseases

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect against parasitic diseases and toxins, plays a role in the expulsion of parasites and larvae from inner tissues to the lumen and outside the body, maintains microbe-rich skin and mucosal epithelial barriers and counterbalances the type 1 immune response and its destructive effects. During the development of a type 2 immune response, an innate immune response initiates starting from epithelial cells and innate lymphoid cells (ILCs), including dendritic cells and macrophages, and translates to adaptive T and B-cell immunity, particularly IgE antibody production. Eosinophils, mast cells and basophils have effects on effector functions. Cytokines from ILC2s and CD4+ helper type 2 (Th2) cells, CD8 + T cells, and NK-T cells, along with myeloid cells, including IL-4, IL-5, IL-9, and IL-13, initiate and sustain allergic inflammation via T cell cells, eosinophils, and ILC2s; promote IgE class switching; and open the epithelial barrier. Epithelial cell activation, alarmin release and barrier dysfunction are key in the development of not only allergic diseases but also many other systemic diseases. Recent biologics targeting the pathways and effector functions of IL4/IL13, IL-5, and IgE have shown promising results for almost all ages, although some patients with severe allergic diseases do not respond to these therapies, highlighting the unmet need for a more detailed and personalized approach.

Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis

Osteoarthritis (OA) poses a significant challenge in orthopedics. Inflammatory pathways are regarded as central mechanisms in the onset and progression of OA. Growing evidence suggests that senescence acts as a mediator in inflammation-induced OA. Given the lack of effective treatments for OA, there is an urgent need for a clearer understanding of its pathogenesis. In this review, we systematically summarize the cross-talk between cellular senescence and inflammation in OA. We begin by focusing on the mechanisms and hallmarks of cellular senescence, summarizing evidence that supports the relationship between cellular senescence and inflammation. We then discuss the mechanisms of interaction between cellular senescence and inflammation, including senescence-associated secretory phenotypes (SASP) and the effects of pro- and anti-inflammatory interventions on cellular senescence. Additionally, we focus on various types of cellular senescence in OA, including senescence in cartilage, subchondral bone, synovium, infrapatellar fat pad, stem cells, and immune cells, elucidating their mechanisms and impacts on OA. Finally, we highlight the potential of therapies targeting senescent cells in OA as a strategy for promoting cartilage regeneration.

Rapid brain tumor classification from sparse epigenomic data

Although the intraoperative molecular diagnosis of the approximately 100 known brain tumor entities described to date has been a goal of neuropathology for the past decade, achieving this within a clinically relevant timeframe of under 1 h after biopsy collection remains elusive. Advances in third-generation sequencing have brought this goal closer, but established machine learning techniques rely on computationally intensive methods, making them impractical for live diagnostic workflows in clinical applications. Here we present MethyLYZR, a naive Bayesian framework enabling fully tractable, live classification of cancer epigenomes. For evaluation, we used nanopore sequencing to classify over 200 brain tumor samples, including 10 sequenced in a clinical setting next to the operating room, achieving highly accurate results within 15 min of sequencing. MethyLYZR can be run in parallel with an ongoing nanopore experiment with negligible computational overhead. Therefore, the only limiting factors for even faster time to results are DNA extraction time and the nanopore sequencer’s maximum parallel throughput. Although more evidence from prospective studies is needed, our study suggests the potential applicability of MethyLYZR for live molecular classification of nervous system malignancies using nanopore sequencing not only for the neurosurgical intraoperative use case but also for other oncologic indications and the classification of tumors from cell-free DNA in liquid biopsies.

Targeting of TAMs: can we be more clever than cancer cells?

With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of conventional therapies needs to consider cancer-specific and patient-specific programming of innate immunity. Intratumoral TAMs and their precursors, resident macrophages and monocytes, are principal regulators of tumor progression and therapy resistance. Our review summarizes the accumulated evidence for the subpopulations of TAMs and their increasing number of biomarkers, indicating their predictive value for the clinical parameters of carcinogenesis and therapy resistance, with a focus on solid cancers of non-infectious etiology. We present the state-of-the-art knowledge about the tumor-supporting functions of TAMs at all stages of tumor progression and highlight biomarkers, recently identified by single-cell and spatial analytical methods, that discriminate between tumor-promoting and tumor-inhibiting TAMs, where both subtypes express a combination of prototype M1 and M2 genes. Our review focuses on novel mechanisms involved in the crosstalk among epigenetic, signaling, transcriptional and metabolic pathways in TAMs. Particular attention has been given to the recently identified link between cancer cell metabolism and the epigenetic programming of TAMs by histone lactylation, which can be responsible for the unlimited protumoral programming of TAMs. Finally, we explain how TAMs interfere with currently used anticancer therapeutics and summarize the most advanced data from clinical trials, which we divide into four categories: inhibition of TAM survival and differentiation, inhibition of monocyte/TAM recruitment into tumors, functional reprogramming of TAMs, and genetic enhancement of macrophages.

Responses

Your email address will not be published. Required fields are marked *